Bio

Francis Chen is a partner in the firm’s Corporate Transactional Group focusing on Public Company Practice. Francis has deep experience advising issuers and underwriters in public and private equity and debt offerings, including initial public offerings, follow-on and secondary financings, and PIPEs. He also counsels public companies regarding U.S. securities and listing compliance and disclosure requirements, as well as general corporate governance matters. He has worked extensively with Chinese and other Asian companies in various industries including biopharmaceutical, energy and agriculture, and with U.S. companies especially early-stage biomedical and biotechnology companies.